Andrew Kolodny
Biographic Data
| ID | 8224697 |
|---|---|
| NAME | Andrew Kolodny |
| GIVEN NAMES | Andrew |
| FAMILY NAME | Kolodny |
| SIGNATURE | KOLODNY A |
| AFFILIATIONS | Heller School for Social Policy and Management, Brandeis University, Waltham, Massachusetts 02454 |
| VERIFIED | No |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 4 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2006 |
| LATEST PUBLICATION YEAR | 2020 |
| H-INDEX | 0 |
How FDA Failures Contributed to the Opioid Crisis
Over the past 25 years, pharmaceutical companies deceptively promoted opioid use in ways that were often neither safe nor effective, contributing to unprecedented increases in prescribing, opioid use disorder, and deaths by overdose. This article explores regulatory mistakes made by the US Food and Drug Administration (FDA) in approving and labeling new analgesics. By understanding and correcting these mistakes, future public health crises caused…
The Prescription Opioid and Heroin Crisis
Public health authorities have described, with growing alarm, an unprecedented increase in morbidity and mortality associated with use of opioid pain relievers (OPRs). Efforts to address the opioid crisis have focused mainly on reducing nonmedical OPR use. Too often overlooked, however, is the need for preventing and treating opioid addiction, which occurs in both medical and nonmedical OPR users. Overprescribing of OPRs has led to a sharp increa…
Psychiatric consequences of methamphetamine use
Introduction
No prominent works on this page.
Psychiatric consequences of methamphetamine use
Introduction
The Prescription Opioid and Heroin Crisis
Public health authorities have described, with growing alarm, an unprecedented increase in morbidity and mortality associated with use of opioid pain relievers (OPRs). Efforts to address the opioid crisis have focused mainly on reducing nonmedical OPR use. Too often overlooked, however, is the need for preventing and treating opioid addiction, which occurs in both medical and nonmedical OPR users. Overprescribing of OPRs has led to a sharp increa…
How FDA Failures Contributed to the Opioid Crisis
Over the past 25 years, pharmaceutical companies deceptively promoted opioid use in ways that were often neither safe nor effective, contributing to unprecedented increases in prescribing, opioid use disorder, and deaths by overdose. This article explores regulatory mistakes made by the US Food and Drug Administration (FDA) in approving and labeling new analgesics. By understanding and correcting these mistakes, future public health crises caused…
Medicine (3 works) · Opioid (2 works) · Opioid Use Disorder Treatment (2 works) · Pain Management and Opioid Use (2 works) · Psychiatry (2 works) · Psychology (2 works) · Addiction (1 works) · Alcoholism and Thiamine Deficiency (1 works) · Artistic and Creative Research (1 works) · Ball (mathematics (1 works)